Akebia Therapeutics Inc, a United States-based biopharmaceutical company that specialises in dialysis and kidney care services, announced on Thursday that it has named LeAnne M Zumwalt as its new director effective 16 February 2021.
Zumwalt has served as group vice president, Government Affairs at DaVita Inc, where she has been employed for 20 years. She has also served on the Adeptus Health and The Advisory Board Company boards of directors.
John P Butler, Akebia Therapeutics president and chief executive officer, said, 'We're honoured to have LeAnne Zumwalt join the Akebia board of directors. Her deep knowledge of and expertise in the US dialysis market, in combination with the financial and public policy leadership roles she has held throughout her career, will be invaluable as we continue to advance our purpose and prepare for the launch of vadadustat, subject to approval.'
Biller Named to Rome Therapeutics Board of Directors
Beck Named Chief Financial Officer at 4D Pharma
Gyroscope Therapeutics names Jessica Stitt as CFO
Campanelli Named to Slayback Board of Directors
Zhang Named Chief Medical Officer at InnoCare
The University of Health Sciences and Pharmacy in St Louis names new president
New COVID-19 virus variant discovered in New York City and Northeast US
NovellusDx Establishes Fore Biotherapeutics US as its Operating company in the United States
Dhingra Named Chairman of the Board of Directors at Lava Therapeutics